$1.48
-0.005-0.34%
Last update: Oct 30, 6:01 AM
Lexicon Pharmaceuticals Inc (LXRX) Stock Price, Quote, News & History
LXRXNASDAQ
Analysts initiate coverage: Buy on IonQ ($60), Jack Henry ($193) and 10X Genomics ($110); Overweight Lexicon ($8); In-Line Fortive ($60).
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) through any online brokerage.
Other companies in Lexicon Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Lexicon Pharmaceuticals has a consensus price target of $4.85.
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $1.46 last updated October 30, 2026 at 6:01 AM EDT.
There are no upcoming dividends for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered...
